03759 PHARMARON
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.80X | Oper Margin | 20.0% |
|---|---|---|---|
| LT Debt/Equity | 35.1% | Net Margin | 14.6% |
| Total Debt/Equity | 43.9% | Return on Equity | 13.2% |
| Price/Book | 2.59X | Return on Assets | 7.5% |
| (HKD 21.220) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 1,907.23 | 1,764.73 | 1,540.64 | 2,031.20 | 1,390.68 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +8.1 | +14.5 | -24.2 | +46.1 | +127.4 |
| Earnings Per Share (HKD) | 1.078 | 0.996 | 0.869 | 1.141 | 0.782 |
| Earnings Per Share Growth (%) | +8.2 | +14.6 | -23.8 | +45.9 | +90.0 |
| Dividend Per Share (HKD) | 0.219 | 0.220 | 0.219 | 0.235 | 0.161 |
| P/E* (X) | 19.69 | 21.31 | 24.42 | 18.60 | 27.14 |
| Yield (%) | 1.03 | 1.04 | 1.03 | 1.11 | 0.76 |
| Dividend Share (%) | 20.30 | 22.08 | 25.22 | 20.58 | 20.60 |
| Book NAV (HKD) | 8.178 | 7.746 | 6.620 | 6.934 | 5.890 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-12-15 21:40:20
Latest Result
| (RMBMn) | 2025-09 | 2024-09 | Chg* (%) | 2023-09 |
| Cover Period (mths) | 9 | 9 | NA | 9 |
|---|---|---|---|---|
| Turnover | 10,086 | 8,817 | +14.4 | 8,560 |
| Operating Result | 1,382 | 1,676 | -17.5 | 1,310 |
| Associates | -53.528 | -53.821 | -0.5 | 11.279 |
| Profit Before Taxation | 1,329 | 1,622 | -18.1 | 1,321 |
| Taxation | 263.063 | 252.669 | +4.1 | 186.423 |
| Profit /( Loss) After Taxation | 1,066 | 1,369 | -22.1 | 1,135 |
| Minority Interests | -75.041 | -52.592 | +42.7 | -4.515 |
| Net Profit | 1,141 | 1,422 | -19.8 | 1,139 |
| Earnings Per Share () | 0.7076 | 0.8890 | -20.4 | 0.6896 |
| Announcement Date | 2025-10-28 | 2024-10-29 | NA | 2023-10-29 |
* Annualised
Last Update Time: 2025-12-15 21:40:25
